InvestorsHub Logo
Followers 55
Posts 6417
Boards Moderated 1
Alias Born 07/28/2015

Re: None

Saturday, 10/08/2022 3:13:31 AM

Saturday, October 08, 2022 3:13:31 AM

Post# of 113754
SBFM’s adva-27a treats breast, pancreatic, and ovarian cancer in this PR:

https://www.globenewswire.com/en/news-release/2022/04/05/2416581/35334/en/Sunshine-Biopharma-s-Newly-Designed-mRNA-Molecules-Prove-Effective-Against-Multidrug-Resistant-Cancer-Cells.html

Lung, uterine, and more cancer here:

https://sunshinebiopharma.com/anticancer-drugs/

Sunshine BioPharma’s Flagship Anticancer Drug adva-27a is effective at killing different types of multidrug resistant cancer cells, and other types including:

* Breast Cancer Cells (MCF-7/MDR)
* Small Cell Lung Cancer Cells (H69AR)
* Uterine Cancer (MES-SA/Dx5)
* Pancreatic Cancer (Panc-1)

Link: https://sunshinebiopharma.com/anticancer-drugs/

Remember Ebola? It treats that too:

https://www.outsourcedpharma.com/doc/lonza-to-manufacture-sunshine-biopharma-s-anti-cancer-compound-0001


As well as many other types of cancer scattered over the last 10-12 years of PRs.

Seems like rat poison or a wonder drug. If it was really so great, why didn’t it get FDA approval?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News